Holen Sie sich die Stockscreener-App
2.12
3.20%
-0.07
Finanzdaten der Minerva Neurosciences Inc-Aktie (NERV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
13.55%
3.3741
|
3.9029 | 4.5222 | 4.3667 | 6.2776 |
| Depreciation and Amortization |
0.07%
0.00136
|
0.00136 | 0.00136 | 0.00136 | 0.00136 |
| Operating Income/Loss |
13.55%
-3.3741
|
-3.9029 | -4.5222 | -4.3667 | -6.2776 |
| Income/Loss From Continuing Operations Before Tax |
13.17%
-3.2586
|
-3.753 | -4.272 | 22.51 | -8.2335 |
| Income/Loss From Continuing Operations After Tax |
13.17%
-3.2586
|
-3.753 | -4.272 | 22.51 | -8.2335 |
|
Net Income/Loss
|
13.17%
-3.2586
|
-3.753 | -4.272 | 22.51 | -8.2335 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.00%
7.569
|
7.569 | - | 7.569 | 7.569 |
| Diluted Average Shares |
0.00%
7.569
|
7.569 | -0.0045 | 7.569 | 7.569 |
| Basic Earnings Per Share |
14.00%
-0.43
|
-0.50 | -0.56 | 2.97 | -1.09 |
| Diluted Earnings Per Share |
14.00%
-0.43
|
-0.50 | -0.56 | 2.97 | -1.09 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):